Ticker archive · $RGEN

$RGEN Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $RGEN — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

?? Negative AI Sentiment (-1.5 / 10)
  • Repligen offers new 0.25% Convertible Senior Notes due 2031 under Item 3.02.
  • Replaces/exchanges existing 1.00% Convertible Senior Notes due 2028.
  • Extends debt maturity and lowers coupon, with standard potential equity dilution risk.
Observed market reaction after signal
4h -9.19%
?? Positive AI Sentiment (+2.5 / 10)
  • Q3 revenue up 11% YoY (12.5% organic) to $209M; closed BioLife acquisition
  • Adjusted EPS rose to $0.53 vs. $0.46 YoY, while GAAP EPS swung to -$0.68 due to acquisition impacts
  • Full-year 2026 revenue guidance raised to $844M-$852M (14.5%-15.5% growth)